^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ovarian Cancer |
| Drug: | cisplatin (DNA synthesis inhibitor) + gemcitabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Acceptable Recurrence Therapies for Epithelial Ovarian (including LCOC) /Fallopian Tube/Primary Peritoneal Cancer...Recurrence Therapy for Platinum-Sensitive Disease...Preferred Regimens...cisplatin/gemcitabine
